| pubmed-article:9820701 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0178784 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0242966 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0163314 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0021708 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0086476 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:9820701 | lifeskim:mentions | umls-concept:C1707491 | lld:lifeskim |
| pubmed-article:9820701 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9820701 | pubmed:dateCreated | 1998-11-25 | lld:pubmed |
| pubmed-article:9820701 | pubmed:abstractText | Intestinal mucosal ischemia and subsequent barrier dysfunction have been related to the development of organ dysfunction and death in the critically ill. We hypothesized that urine concentrations of intestinal fatty acid binding protein (IFABP), a sensitive marker of intestinal ischemia, might predict the development of the systemic inflammatory response syndrome (SIRS) and organ dysfunction. | lld:pubmed |
| pubmed-article:9820701 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9820701 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9820701 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9820701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9820701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9820701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9820701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9820701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9820701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9820701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9820701 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9820701 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9820701 | pubmed:issn | 0022-5282 | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:FischerBB | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:MollerBB | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:BurnsGG | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:CohnSS | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:MarksW HWH | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:LiebermanJ... | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:SacchettiniJJ | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:JaicksRR | lld:pubmed |
| pubmed-article:9820701 | pubmed:author | pubmed-author:WoodeLL | lld:pubmed |
| pubmed-article:9820701 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9820701 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:9820701 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9820701 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9820701 | pubmed:pagination | 900-6 | lld:pubmed |
| pubmed-article:9820701 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:meshHeading | pubmed-meshheading:9820701-... | lld:pubmed |
| pubmed-article:9820701 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9820701 | pubmed:articleTitle | Organ failure, infection, and the systemic inflammatory response syndrome are associated with elevated levels of urinary intestinal fatty acid binding protein: study of 100 consecutive patients in a surgical intensive care unit. | lld:pubmed |
| pubmed-article:9820701 | pubmed:affiliation | Department of Organ Transplantation, Swedish Medical Center, Seattle, Washington, USA. | lld:pubmed |
| pubmed-article:9820701 | pubmed:publicationType | Journal Article | lld:pubmed |
